Key terms
About DXCM
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest DXCM news
Yesterday
5:55am ET
TipRanks’ ‘Perfect 10’ List: Analysts Pound the Table on These Top-Scoring Stocks
Mar 12
9:51am ET
Oracle, Dollar General upgraded: Wall Street’s top analyst calls
Mar 12
6:28am ET
RBC starts DexCom with Outperform on multi-year runway
Mar 12
5:25am ET
Wells Fargo Remains a Buy on Dexcom (DXCM)
Mar 12
5:05am ET
DexCom initiated with an Outperform at RBC Capital
Mar 11
1:10am ET
Analysts Are Bullish on These Healthcare Stocks: Wave Life Sciences (WVE), Dexcom (DXCM)
Mar 06
9:55am ET
Early notable gainers among liquid option names on March 6th
Mar 06
7:35am ET
Piper Sandler Sticks to Its Buy Rating for Dexcom (DXCM)
Mar 06
6:27am ET
Dexcom’s Stelo Launch Fuels Buy Rating on Expansive Market Opportunity
Mar 06
6:02am ET
DexCom’s (NASDAQ:DXCM) Stelo Becomes the First Glucose Monitor to be Cleared for OTC Use
Mar 06
6:01am ET
Analysts Conflicted on These Healthcare Names: AMN Healthcare Services (AMN) and Dexcom (DXCM)
Mar 05
9:31pm ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Dexcom (DXCM), Orthofix (OFIX) and Medtronic (MDT)
Mar 05
4:27pm ET
DexCom announces FDA clears Stelo biosensor
Mar 05
5:31am ET
DexCom announces new CGM data, direct to Apple Watch functionality in Q2
Mar 01
2:25pm ET
DexCom call volume above normal and directionally bullish
Mar 01
7:50am ET
Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS), Azitra Inc (AZTR) and Dexcom (DXCM)
Feb 15
4:40pm ET
Dexcom Finalizes Stock Warrant Termination and Equity Deals
Feb 14
12:58pm ET
Coleman’s Tiger Global bought Broadcom and DexCom during Q4
Feb 13
6:00am ET
Analysts Offer Insights on Healthcare Companies: Molina Healthcare (MOH), Dexcom (DXCM) and Tenaya Therapeutics (TNYA)
Feb 13
5:10am ET
Dexcom: A Strong Buy on Robust Performance and Growth Prospects
Feb 12
3:51am ET
Analysts Offer Insights on Healthcare Companies: Zoetis (ZTS), Dexcom (DXCM) and Gilead Sciences (GILD)
Feb 10
1:00am ET
A New Cause for Concern: Dexcom Adds a New Natural and Human Disruptions Risk
Feb 09
8:01am ET
Analysts Are Bullish on Top Healthcare Stocks: Denali Therapeutics (DNLI), Illumina (ILMN)
Feb 09
7:51am ET
DexCom price target raised to $160 from $110 at TD Cowen
Feb 09
7:31am ET
DexCom price target raised to $144 from $140 at Canaccord
Feb 08
10:05pm ET
Dexcom’s Strong Performance and Expansion Strategies Merit a Buy Rating
Feb 08
4:03pm ET
DexCom backs FY24 revenue roughly $4.15B-$4.35B, consensus $4.33B
Feb 08
4:03pm ET
DexCom reports Q4 adjusted EPS 50c, consensus 43c
Feb 08
2:49pm ET
DexCom options imply 6.6% move in share price post-earnings
Feb 08
1:36pm ET
Notable companies reporting after market close
Feb 06
5:51am ET
Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Vaxcyte (PCVX) and Vertex Pharmaceuticals (VRTX)
No recent press releases are available for DXCM
DXCM Financials
Key terms
Ad Feedback
DXCM Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
DXCM Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range